Alexion Pharmaceuticals (ALXN) 180.26 $ALXN
Stocks Finish Lower for the Week as Fed Talk Spooks Investors
at The Street - Fri Mar 27, 3:20PM CDT
Wall Street ends its four-day losing streak on Friday, but the minor gains are nowhere near enough to erase big losses suffered over the week.
BIIB: 431.62 (+1.75), VRTX: 121.25 (+0.91), BMRN: 129.13 (+0.35), MON: 113.38 (+0.65), IBB: 351.32 (+3.86), SOXX: 95.09 (+1.20), NXPI: 102.43 (+2.51), KMX: 69.22 (+2.53), AYI: 172.57 (+4.57), AA: 12.96 (+0.26), TXN: 58.00 (+1.24), ADI: 64.81 (+5.97), ALXN: 180.26 (-0.33), AVGO: 130.55 (+2.34), REGN: 459.78 (+5.28)
Stock Markets Hold Onto Slight Gains Ahead of Yellen Speech
at The Street - Fri Mar 27, 2:11PM CDT
Stocks inch higher on Friday afternoon, recovering from an earlier drop.
BIIB: 431.62 (+1.75), VRTX: 121.25 (+0.91), BMRN: 129.13 (+0.35), GME: 37.69 (-0.67), OLN: 32.41 (+1.41), BBRY: 8.80 (-0.66), IBB: 351.32 (+3.86), HPQ: 31.57 (+0.08), YHOO: 44.95 (-0.15), ALXN: 180.26 (-0.33), DOW: 48.68 (+0.92), REGN: 459.78 (+5.28)
Stocks Turn Flat in Bumpy Session; Crude Settles Above $51
at The Street - Thu Mar 26, 1:53PM CDT
Stocks recover from heavy losses suffered earlier Thursday.
IBB: 351.32 (+3.86), MYL: 60.00 (-1.63), LULU: 64.83 (+0.51), SLB: 84.48 (+1.17), CELG: 120.02 (+1.34), GILD: 100.69 (-0.31), ALXN: 180.26 (-0.33), RHT: 76.69 (+0.17), TWC: 149.27 (+1.99), CMCSA: 56.61 (+0.67)
Biotech Stock Selloff: Is It Justified?
at Investor's Business Daily - Thu Mar 26, 11:12AM CDT
Biotech stocks continued to slide Thursday, prompting analysts to weigh in on the causes and prognosis for the sector. Piper Jaffray's Joshua Schimmer noted that the same thing happened about a year ago, sparked by the price debate over Gilead...
BIIB: 431.62 (+1.75), VRTX: 121.25 (+0.91), BMRN: 129.13 (+0.35), KITE: 59.98 (+0.20), GILD: 100.69 (-0.31), ALXN: 180.26 (-0.33), JUNO: 60.66 (+4.06), CELG: 120.02 (+1.34)
Stock Market News for March 26, 2015 - Market News
Zacks Equity Research - Zacks Investment Research - Thu Mar 26, 9:10AM CDT
Slump in biotech and technology stocks sent benchmarks to negative territory for third straight sessions on Wednesday
BIIB: 431.62 (+1.75), FB: 83.19 (-0.11), XOM: 85.63 (+2.05), KRFT: 90.61 (+1.51), SLB: 84.48 (+1.17), GILD: 100.69 (-0.31), ALXN: 180.26 (-0.33), GOOGL: 561.13 (+3.58), BRK.B: 145.98 (+2.09), MSFT: 40.96 (-0.01), CVX: 106.90 (+2.62), AAPL: 126.37 (+3.12), REGN: 459.78 (+5.28)
Big Selloff on Wall Street as Stocks Plummet on Fed Jitters
at The Street - Wed Mar 25, 3:27PM CDT
Wednesday was a kick-you-in-the-guts kind of day.
MU: 26.68 (+0.01), XOM: 85.63 (+2.05), IBB: 351.32 (+3.86), KRFT: 90.61 (+1.51), SOXX: 95.09 (+1.20), KFX: 10.95 (+0.03), NVDA: 21.47 (+0.09), RDS.A: 60.93 (+0.45), AMD: 2.70 (-0.02), ALXN: 180.26 (-0.33), NLNK: 56.40 (+4.14), BP: 39.84 (+0.23), ARIA: 8.56 (+0.17), CVX: 106.90 (+2.62), XLE: 78.04 (+1.64), LXK: 43.13 (-0.17)
Stocks Sell Off on Fed Jitters; Oil Rallies as Yemen Fights Intensify
at The Street - Wed Mar 25, 2:22PM CDT
Stocks are lower in a volatile trading session on Wednesday.
MU: 26.68 (+0.01), IBB: 351.32 (+3.86), KRFT: 90.61 (+1.51), SOXX: 95.09 (+1.20), KFX: 10.95 (+0.03), NVDA: 21.47 (+0.09), AMD: 2.70 (-0.02), ALXN: 180.26 (-0.33), NLNK: 56.40 (+4.14), ARIA: 8.56 (+0.17), BRK.A: 219,700.00 (+2,699.92), LXK: 43.13 (-0.17)
Stocks Climb, Nasdaq Leads Markets as Health Care Rebounds
at The Street - Tue Mar 24, 10:11AM CDT
Stocks rose slightly on Tuesday.
AMZN: 374.59 (+4.03), ABMD: 73.47 (+3.16), VRTX: 121.25 (+0.91), GILD: 100.69 (-0.31), FB: 83.19 (-0.11), CHK: 13.97 (-0.06), HDS: 31.41 (+1.18), ALXN: 180.26 (-0.33), GOOGL: 561.13 (+3.58), GOOG: 552.03 (+3.69)
Jim Cramer Digs Into Dozens of Charts, Finds 7 Pillars of Health Care Strength
at The Street - Mon Mar 23, 1:18PM CDT
Investors can handily beat the average by developing a portfolio of health care companies that try to service the colossus that is the American medical system.
BIIB: 431.62 (+1.75), BMRN: 129.13 (+0.35), ISIS: 64.81 (+1.44), ALXN: 180.26 (-0.33), AMGN: 164.30 (+1.71)
Insider Trading Alert - SFLY, NUAN And ALXN Traded By Insiders
at The Street - Mon Mar 23, 11:33AM CDT
Stocks with insider trader activity include SFLY, NUAN and ALXN
NUAN: 14.16 (+0.12), ALXN: 180.26 (-0.33), SFLY: 45.88 (+0.16)
'Fast Money' Recap: How to Buy Into Biotech Without Going Crazy
at The Street - Sat Mar 21, 4:00AM CDT
The trading panel looked at biotech stocks and exchange-traded funds and debated the benefits of Google versus Facebook.
TUR: 46.97 (+0.99), EEM: 40.22 (+0.76), BIIB: 431.62 (+1.75), GILD: 100.69 (-0.31), CLVS: 74.95 (+1.51), FB: 83.19 (-0.11), GLD: 113.75 (-1.31), ALXN: 180.26 (-0.33), IBB: 351.32 (+3.86), AMGN: 164.30 (+1.71), GOOGL: 561.13 (+3.58), MTW: 21.76 (+0.59), CELG: 120.02 (+1.34)
Learn The ABC's Of 3 Top-Ranked Biotech Stocks
at Investor's Business Daily - Fri Mar 20, 4:51PM CDT
The Medical-Biomed/Biotech group for eight straight weeks has been ranked No. 1 out of the 197 industry groups that IBD tracks. That means the group is bolstered by some of the best-performing stocks in the market. In this video, we analyze the...
BIIB: 431.62 (+1.75), ALXN: 180.26 (-0.33), CELG: 120.02 (+1.34)
Alexion Pharmaceuticals (ALXN) On Momo Momentum Watch Today
at The Street - Fri Mar 20, 8:49AM CDT
Trade-Ideas LLC identified Alexion Pharmaceuticals (ALXN) as a momo momentum candidate
ALXN: 180.26 (-0.33)
Can This Biotech Stock Go from Good to Great?
Keith Speights, The Motley Fool - Motley Fool - Thu Mar 19, 3:03PM CDT
Source: Alexion Pharmaceuticals How can you distinguish a great biotech stock from a good one? Opinions will vary, but here are a few ideas. The biotech should be profitable and on the path to even higher earnings. Its financial performance...
BIIB: 431.62 (+1.75), ALXN: 180.26 (-0.33), IBB: 351.32 (+3.86), AMGN: 164.30 (+1.71)
Look for Shares of Alexion Pharmaceuticals to Potentially Pullback after Yesterday's 3.15% Rise
Comtex SmarTrend(R) - Tue Mar 17, 3:57PM CDT
Alexion Pharmaceuticals (NASDAQ:ALXN) traded in a range yesterday that spanned from a low of $176.76 to a high of $184.75. Yesterday, the shares gained 3.1%, which took the trading range above the 3-day high of $181.97 on volume of 1.6 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
ALXN: 180.26 (-0.33)
3 Biotech Stocks Wall Street Loves
Keith Speights, The Motley Fool - Motley Fool - Mon Mar 16, 7:01AM CDT
Source: Wikimedia Commons . How can you know when Wall Street really loves a stock? One key sign is how many of the analysts covering the stock maintain buy ratings. Another tell-tale indicator is the price targets these analysts give for the...
GILD: 100.69 (-0.31), ALXN: 180.26 (-0.33), CELG: 120.02 (+1.34)
Affymetrix Hits 52-Week High on Stellar Q4, Positive Outlook - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Mar 13, 12:20PM CDT
Shares of Affymetrix Inc. (AFFX) scaled a new 52-week high of $12.49 on Mar 12, eventually closing lower at $12.36.
CBM: 35.59 (+0.66), ANIP: 62.93 (+0.99), ALXN: 180.26 (-0.33), AFFX: 12.86 (+0.15)
Alexion Pharmaceuticals Falls 1.36% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Wed Mar 11, 4:06PM CDT
Alexion Pharmaceuticals (NASDAQ:ALXN) traded in a range yesterday that spanned from a low of $177.38 to a high of $181.75. Yesterday, the shares fell 1.4%, which took the trading range below the 3-day low of $180.37 on volume of 1.2 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
ALXN: 180.26 (-0.33)
Coverage of Biotech Equities -- MannKind, Novavax, Curis, Pharmacyclics, and Alexion Pharma
PR Newswire - Tue Mar 10, 8:35AM CDT
Editor Note: For more information about this release, please scroll to bottom.
CRIS: 2.50 (-0.04), PCYC: 256.43 (-0.12), NVAX: 8.64 (+0.42), ALXN: 180.26 (-0.33), MNKD: 5.34 (+0.10)
New Data from First Natural History Study in Juveniles with Hypophosphatasia (HPP) Showing Substantial Disease Burden, Including Musculoskeletal Abnormalities and Growth Deficiencies, Presented in Late-Breaking Oral Session at ENDO 2015
Business Wire - Sat Mar 07, 3:22PM CST
--Significant improvements in physical function and muscle strength observed in children with HPP treated with asfotase alfa for three or more years in Phase 2 study
ALXN: 180.26 (-0.33)
Stocks Finish Lower for the Week as Fed Talk Spooks Investors
at The Street - Fri Mar 27, 3:20PM CDT
Wall Street ends its four-day losing streak on Friday, but the minor gains are nowhere near enough to erase big losses suffered over the week.
BIIB: 431.62 (+1.75), VRTX: 121.25 (+0.91), BMRN: 129.13 (+0.35), MON: 113.38 (+0.65), IBB: 351.32 (+3.86), SOXX: 95.09 (+1.20), NXPI: 102.43 (+2.51), KMX: 69.22 (+2.53), AYI: 172.57 (+4.57), AA: 12.96 (+0.26), TXN: 58.00 (+1.24), ADI: 64.81 (+5.97), ALXN: 180.26 (-0.33), AVGO: 130.55 (+2.34), REGN: 459.78 (+5.28)
Stock Markets Hold Onto Slight Gains Ahead of Yellen Speech
at The Street - Fri Mar 27, 2:11PM CDT
Stocks inch higher on Friday afternoon, recovering from an earlier drop.
BIIB: 431.62 (+1.75), VRTX: 121.25 (+0.91), BMRN: 129.13 (+0.35), GME: 37.69 (-0.67), OLN: 32.41 (+1.41), BBRY: 8.80 (-0.66), IBB: 351.32 (+3.86), HPQ: 31.57 (+0.08), YHOO: 44.95 (-0.15), ALXN: 180.26 (-0.33), DOW: 48.68 (+0.92), REGN: 459.78 (+5.28)
Stocks Turn Flat in Bumpy Session; Crude Settles Above $51
at The Street - Thu Mar 26, 1:53PM CDT
Stocks recover from heavy losses suffered earlier Thursday.
IBB: 351.32 (+3.86), MYL: 60.00 (-1.63), LULU: 64.83 (+0.51), SLB: 84.48 (+1.17), CELG: 120.02 (+1.34), GILD: 100.69 (-0.31), ALXN: 180.26 (-0.33), RHT: 76.69 (+0.17), TWC: 149.27 (+1.99), CMCSA: 56.61 (+0.67)
Biotech Stock Selloff: Is It Justified?
at Investor's Business Daily - Thu Mar 26, 11:12AM CDT
Biotech stocks continued to slide Thursday, prompting analysts to weigh in on the causes and prognosis for the sector. Piper Jaffray's Joshua Schimmer noted that the same thing happened about a year ago, sparked by the price debate over Gilead...
BIIB: 431.62 (+1.75), VRTX: 121.25 (+0.91), BMRN: 129.13 (+0.35), KITE: 59.98 (+0.20), GILD: 100.69 (-0.31), ALXN: 180.26 (-0.33), JUNO: 60.66 (+4.06), CELG: 120.02 (+1.34)
Stock Market News for March 26, 2015 - Market News
Zacks Equity Research - Zacks Investment Research - Thu Mar 26, 9:10AM CDT
Slump in biotech and technology stocks sent benchmarks to negative territory for third straight sessions on Wednesday
BIIB: 431.62 (+1.75), FB: 83.19 (-0.11), XOM: 85.63 (+2.05), KRFT: 90.61 (+1.51), SLB: 84.48 (+1.17), GILD: 100.69 (-0.31), ALXN: 180.26 (-0.33), GOOGL: 561.13 (+3.58), BRK.B: 145.98 (+2.09), MSFT: 40.96 (-0.01), CVX: 106.90 (+2.62), AAPL: 126.37 (+3.12), REGN: 459.78 (+5.28)
Big Selloff on Wall Street as Stocks Plummet on Fed Jitters
at The Street - Wed Mar 25, 3:27PM CDT
Wednesday was a kick-you-in-the-guts kind of day.
MU: 26.68 (+0.01), XOM: 85.63 (+2.05), IBB: 351.32 (+3.86), KRFT: 90.61 (+1.51), SOXX: 95.09 (+1.20), KFX: 10.95 (+0.03), NVDA: 21.47 (+0.09), RDS.A: 60.93 (+0.45), AMD: 2.70 (-0.02), ALXN: 180.26 (-0.33), NLNK: 56.40 (+4.14), BP: 39.84 (+0.23), ARIA: 8.56 (+0.17), CVX: 106.90 (+2.62), XLE: 78.04 (+1.64), LXK: 43.13 (-0.17)
Stocks Sell Off on Fed Jitters; Oil Rallies as Yemen Fights Intensify
at The Street - Wed Mar 25, 2:22PM CDT
Stocks are lower in a volatile trading session on Wednesday.
MU: 26.68 (+0.01), IBB: 351.32 (+3.86), KRFT: 90.61 (+1.51), SOXX: 95.09 (+1.20), KFX: 10.95 (+0.03), NVDA: 21.47 (+0.09), AMD: 2.70 (-0.02), ALXN: 180.26 (-0.33), NLNK: 56.40 (+4.14), ARIA: 8.56 (+0.17), BRK.A: 219,700.00 (+2,699.92), LXK: 43.13 (-0.17)
Stocks Climb, Nasdaq Leads Markets as Health Care Rebounds
at The Street - Tue Mar 24, 10:11AM CDT
Stocks rose slightly on Tuesday.
AMZN: 374.59 (+4.03), ABMD: 73.47 (+3.16), VRTX: 121.25 (+0.91), GILD: 100.69 (-0.31), FB: 83.19 (-0.11), CHK: 13.97 (-0.06), HDS: 31.41 (+1.18), ALXN: 180.26 (-0.33), GOOGL: 561.13 (+3.58), GOOG: 552.03 (+3.69)
Jim Cramer Digs Into Dozens of Charts, Finds 7 Pillars of Health Care Strength
at The Street - Mon Mar 23, 1:18PM CDT
Investors can handily beat the average by developing a portfolio of health care companies that try to service the colossus that is the American medical system.
BIIB: 431.62 (+1.75), BMRN: 129.13 (+0.35), ISIS: 64.81 (+1.44), ALXN: 180.26 (-0.33), AMGN: 164.30 (+1.71)
Insider Trading Alert - SFLY, NUAN And ALXN Traded By Insiders
at The Street - Mon Mar 23, 11:33AM CDT
Stocks with insider trader activity include SFLY, NUAN and ALXN
NUAN: 14.16 (+0.12), ALXN: 180.26 (-0.33), SFLY: 45.88 (+0.16)
'Fast Money' Recap: How to Buy Into Biotech Without Going Crazy
at The Street - Sat Mar 21, 4:00AM CDT
The trading panel looked at biotech stocks and exchange-traded funds and debated the benefits of Google versus Facebook.
TUR: 46.97 (+0.99), EEM: 40.22 (+0.76), BIIB: 431.62 (+1.75), GILD: 100.69 (-0.31), CLVS: 74.95 (+1.51), FB: 83.19 (-0.11), GLD: 113.75 (-1.31), ALXN: 180.26 (-0.33), IBB: 351.32 (+3.86), AMGN: 164.30 (+1.71), GOOGL: 561.13 (+3.58), MTW: 21.76 (+0.59), CELG: 120.02 (+1.34)
Learn The ABC's Of 3 Top-Ranked Biotech Stocks
at Investor's Business Daily - Fri Mar 20, 4:51PM CDT
The Medical-Biomed/Biotech group for eight straight weeks has been ranked No. 1 out of the 197 industry groups that IBD tracks. That means the group is bolstered by some of the best-performing stocks in the market. In this video, we analyze the...
BIIB: 431.62 (+1.75), ALXN: 180.26 (-0.33), CELG: 120.02 (+1.34)
Alexion Pharmaceuticals (ALXN) On Momo Momentum Watch Today
at The Street - Fri Mar 20, 8:49AM CDT
Trade-Ideas LLC identified Alexion Pharmaceuticals (ALXN) as a momo momentum candidate
ALXN: 180.26 (-0.33)
Can This Biotech Stock Go from Good to Great?
Keith Speights, The Motley Fool - Motley Fool - Thu Mar 19, 3:03PM CDT
Source: Alexion Pharmaceuticals How can you distinguish a great biotech stock from a good one? Opinions will vary, but here are a few ideas. The biotech should be profitable and on the path to even higher earnings. Its financial performance...
BIIB: 431.62 (+1.75), ALXN: 180.26 (-0.33), IBB: 351.32 (+3.86), AMGN: 164.30 (+1.71)
Look for Shares of Alexion Pharmaceuticals to Potentially Pullback after Yesterday's 3.15% Rise
Comtex SmarTrend(R) - Tue Mar 17, 3:57PM CDT
Alexion Pharmaceuticals (NASDAQ:ALXN) traded in a range yesterday that spanned from a low of $176.76 to a high of $184.75. Yesterday, the shares gained 3.1%, which took the trading range above the 3-day high of $181.97 on volume of 1.6 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
ALXN: 180.26 (-0.33)
3 Biotech Stocks Wall Street Loves
Keith Speights, The Motley Fool - Motley Fool - Mon Mar 16, 7:01AM CDT
Source: Wikimedia Commons . How can you know when Wall Street really loves a stock? One key sign is how many of the analysts covering the stock maintain buy ratings. Another tell-tale indicator is the price targets these analysts give for the...
GILD: 100.69 (-0.31), ALXN: 180.26 (-0.33), CELG: 120.02 (+1.34)
Affymetrix Hits 52-Week High on Stellar Q4, Positive Outlook - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Mar 13, 12:20PM CDT
Shares of Affymetrix Inc. (AFFX) scaled a new 52-week high of $12.49 on Mar 12, eventually closing lower at $12.36.
CBM: 35.59 (+0.66), ANIP: 62.93 (+0.99), ALXN: 180.26 (-0.33), AFFX: 12.86 (+0.15)
Alexion Pharmaceuticals Falls 1.36% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Wed Mar 11, 4:06PM CDT
Alexion Pharmaceuticals (NASDAQ:ALXN) traded in a range yesterday that spanned from a low of $177.38 to a high of $181.75. Yesterday, the shares fell 1.4%, which took the trading range below the 3-day low of $180.37 on volume of 1.2 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
ALXN: 180.26 (-0.33)
Coverage of Biotech Equities -- MannKind, Novavax, Curis, Pharmacyclics, and Alexion Pharma
PR Newswire - Tue Mar 10, 8:35AM CDT
Editor Note: For more information about this release, please scroll to bottom.
CRIS: 2.50 (-0.04), PCYC: 256.43 (-0.12), NVAX: 8.64 (+0.42), ALXN: 180.26 (-0.33), MNKD: 5.34 (+0.10)
New Data from First Natural History Study in Juveniles with Hypophosphatasia (HPP) Showing Substantial Disease Burden, Including Musculoskeletal Abnormalities and Growth Deficiencies, Presented in Late-Breaking Oral Session at ENDO 2015
Business Wire - Sat Mar 07, 3:22PM CST
--Significant improvements in physical function and muscle strength observed in children with HPP treated with asfotase alfa for three or more years in Phase 2 study
ALXN: 180.26 (-0.33)
